Kestra Medical Technologies, LTD. income statement

In fiscal 2026, Kestra Medical Technologies, LTD. reported revenue of $95.1m, up 59.0% on the year before, operating income of −$135m (a -141.6% margin) and net income of −$132m, or −$2.43 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Kestra Medical Technologies, LTD.: income statement, annual
Fiscal year	2024Apr 2024	2025Apr 2025	2026Apr 2026	LTMJul 2026
Revenue	28	60	95	107
Cost of revenue	27	36	46	49
Gross profit	0	24	49	58
Research and development	15	16	19	22
Selling, general and administrative	70	115	164	179
Operating income	−85	−106	−135	−144
Interest expense	6	8	8	8
Income before tax	−94	−114	−131	−150
Income tax	0	0	0	0
Net income	−94	−114	−132	−150
Diluted EPS	−$5.07	−$5.13	−$2.43	−$2.68
Diluted shares (average)	20m	25m	54m	56m
EBITDA	−74	−98	−126	−134

US$ millions unless shown otherwise. Fiscal quarters.

Kestra Medical Technologies, LTD.: income statement, quarterly
Quarter	2025 Q2Oct 2024	2025 Q3Jan 2025	2025 Q4Apr 2025	2026 Q1Jul 2025	2026 Q2Oct 2025	2026 Q3Jan 2026	2026 Q4Apr 2026	2027 Q1Jul 2026
Revenue	15	15	17	19	23	25	29	31
Cost of revenue	9	9	10	11	11	12	13	13
Gross profit	6	7	8	9	11	13	16	17
Research and development	4	3	5	4	5	5	6	7
Selling, general and administrative	21	24	50	34	38	43	49	48
Operating income	−19	−21	−48	−29	−32	−35	−39	−38
Interest expense	2	2	2	2	2	2	2	2
Income before tax	−21	−22	−51	−26	−33	−34	−39	−44
Income tax	0	0	0	0	0	0	0	0
Net income	−20	−22	−52	−26	−33	−34	−39	−44
Diluted EPS	−$1.19	−$1.25	−$1.57	−$0.50	−$0.64	−$0.61	−$0.67	−$0.75
EBITDA	−17	−19	−46	−27	−29	−33	−37	−35

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: KMTS vs XTNT KMTS vs SMTI CBLL vs KMTS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Kestra Medical Technologies, LTD.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Kestra Medical Technologies, LTD.